Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01689662
What this trial is testing

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Endocyte 40
Not applicableStudy completedNCT06345183
What this trial is testing

Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)
Bristol-Myers Squibb 327
Testing effectiveness (Phase 2)Study completedNCT00083941
What this trial is testing

TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
Oxford BioMedica 25
Not applicableUnknownNCT03738488
What this trial is testing

3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular Involvement

Who this might be right for
Renal Cell CarcinomaThree-DimensionalVenous Thromboses
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 10
Testing effectiveness (Phase 2)Ended earlyNCT02626754
What this trial is testing

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Who this might be right for
Renal Cell Carcinoma
vghtpe user 13
Not applicableStudy completedNCT03133286
What this trial is testing

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Who this might be right for
Radiation TherapyCancerCancer of Anus+16 more
DxTerity Diagnostics 16
Not applicableStudy completedNCT01968447
What this trial is testing

Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex

Who this might be right for
Prostate CancerRenal Cancer
Leiden University Medical Center 40
Not applicableEnded earlyNCT01195649
What this trial is testing

Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based Therapy

Who this might be right for
Carcinoma, Renal Cell
Bayer 11
Testing effectiveness (Phase 2)Ended earlyNCT01392352
What this trial is testing

HYPAZ: Hypertension Induced by Pazopanib

Who this might be right for
Renal Cell CarcinomaSoft Tissue SarcomaGlioblastoma+8 more
Cambridge University Hospitals NHS Foundation Trust 31
Not applicableStudy completedNCT05858749
What this trial is testing

Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 494
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableTemporarily pausedNCT05210933
What this trial is testing

Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry

Who this might be right for
Renal Cancer
University of Alberta 750
Not applicableStudy completedNCT02499458
What this trial is testing

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

Who this might be right for
Clear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial Cells+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 44
Early research (Phase 1)Study completedNCT02035358
What this trial is testing

Immunotherapy Study for Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Clear-cell Renal CancerRecurrent Renal Cell Carcinoma+2 more
NewLink Genetics Corporation 18
Testing effectiveness (Phase 2)Looking for participantsNCT07023432
What this trial is testing

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

Who this might be right for
Active SurveillanceClear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 78
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Large-scale testing (Phase 3)Study completedNCT00053807
What this trial is testing

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

Who this might be right for
Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC 96
Testing effectiveness (Phase 2)Ended earlyNCT01160445
What this trial is testing

Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer

Who this might be right for
Metastatic MelanomaMetastatic Renal Cancer
National Cancer Institute (NCI) 9
Post-approval studies (Phase 4)Study completedNCT01402089
What this trial is testing

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Who this might be right for
Non Small-cell Lung CancerRenal-cell CancerGastrointestinal Stroma Tumor
Markus Joerger 54
Not applicableStudy completedNCT04329767
What this trial is testing

A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy

Who this might be right for
Kidney Cancer
Intuitive Surgical 122
Next Page